查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球呼吸道合胞病毒诊断市场研究报告 - 2023 年至 2030 年产业分析、规模、份额、成长、趋势与预测
市场调查报告书
商品编码
1377881

全球呼吸道合胞病毒诊断市场研究报告 - 2023 年至 2030 年产业分析、规模、份额、成长、趋势与预测

Global Respiratory Syncytial Virus Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 157 Pages | 商品交期: 最快1-2个工作天内

价格

预计到 2030 年，全球呼吸道合胞病毒诊断市场的市场规模将从 2022 年的 998.2 万美元达到近 2,171.05 万美元，在 2023 年至 2030 年的研究期间CAGR为 10.2%。

呼吸道合胞病毒 (RSV) 诊断是指用于检测和识别呼吸道合胞病毒（一种主要影响呼吸系统的常见病毒病原体）的各种测试和方法。该病毒是婴儿、幼儿和老年人呼吸道感染的主要原因，可导致从轻度感冒样症状到严重呼吸道疾病的病症，尤其是在弱势群体中。准确、及时的 RSV 诊断对于适当的患者管理和感染控制至关重要。

市场动态：

呼吸道合胞病毒 (RSV) 诊断市场正在几个关键因素的推动下成长。 RSV 是一种常见的呼吸道病毒，可导致严重疾病，尤其是婴儿、老年人和免疫系统较弱的人。这种流行，加上季节性爆发，强调了准确和及时诊断的必要性。诊断技术的进步，包括 PCR 和即时检测 (POCT) 等分子检测，提高了 RSV 检测的灵敏度和速度，使诊断更加高效和方便。快速 POCT 的可用性在临床环境中特别有价值，可以减少对复杂实验室检测的依赖。人们（尤其是医疗保健专业人员）对 RSV 影响的认识不断提高，促使人们更多地考虑 RSV 检测，特别是在儿科和老年护理领域。公共卫生准备和监测也依赖 RSV 诊断来追踪和应对疫情。此外，全球人口老化和旅行全球化增加了各个地区严重 RSV 感染的风险，进一步推动了对诊断的需求。随着创新诊断技术的不断发展以及人们对 RSV 严重性的认识不断增强，RSV 诊断市场预计将进一步扩大，确保及早识别和干预这种重要的呼吸道病毒。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球呼吸道合胞病毒诊断市场的每个细分市场进行了包容性评估。呼吸道合胞病毒诊断产业的成长和趋势为这项研究提供了整体方法。

区域分析：

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲呼吸道合胞病毒诊断市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。呼吸道合胞病毒诊断市场的主要参与者包括 Becton、Dickinson, and Company、Novartis AG、Abbott、Ortho Clinical Diagnostics、Thermo Fisher Scientific Inc.、Bio-Rad Laboratories, Inc.、F. Hoffmann-La Roche Ltd.、 BIOMERIEUX、DiaSorin SpA、Merck KGaA、Quidel Corp.、Coris BioConcept、Siemens Healthcare SA、Quest Diagnostics Inc. 本部分包含竞争格局的整体视图，其中包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概览、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：呼吸道合胞病毒诊断 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按产品分類的市场吸引力分析
    • 按最终用途分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球呼吸道合胞病毒诊断市场分析：按产品

  • 按产品概述
  • 历史和预测数据
  • 按产品分析
  • 直接萤光抗体 (Dfa) 法
  • 快速抗原诊断测试 (Radt)
  • 分子诊断
  • 色谱免疫分析（重力驱动测试，Oligo 色谱 (Oc)）
  • 诊断影像
  • 凝胶微滴
  • 流式细胞仪
  • 其他的

第 6 章：全球呼吸道合胞病毒诊断市场分析：依最终用途分类

  • 按最终用途分類的概述
  • 历史和预测数据
  • 按最终用途分析
  • 医院
  • 实验室
  • 诊所
  • 居家护理

第 7 章：全球呼吸道合胞病毒诊断市场分析：依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区国家/地区销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 8 章：呼吸道合胞病毒诊断公司的竞争格局

  • 呼吸道合胞病毒诊断市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 9 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Becton
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Dickinson and Company
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Novartis AG
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Abbott
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Ortho Clinical Diagnostics
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Thermo Fisher Scientific Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Bio-Rad Laboratories Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • F. Hoffmann-La Roche Ltd.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • BIOMERIEUX
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • DiaSorin SpA
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Merck KGaA
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Quidel Corp.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Coris BioConcept
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Siemens Healthcare SA
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Quest Diagnostics Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

Product Code: VMR112112234

The global demand for Respiratory Syncytial Virus Diagnostics Market is presumed to reach the market size of nearly USD 2171.05 MN by 2030 from USD 998.2 MN in 2022 with a CAGR of 10.2% under the study period 2023 - 2030.

Respiratory syncytial virus (RSV) diagnostics refer to the various tests and methods used to detect and identify respiratory syncytial virus, a common viral pathogen that primarily affects the respiratory system. The virus is a major cause of respiratory tract infections in infants, young children, and older adults, and it can lead to conditions ranging from mild cold-like symptoms to severe respiratory illness, especially in vulnerable populations. Accurate and timely diagnosis of RSV is crucial for appropriate patient management and infection control.

MARKET DYNAMICS:

The Respiratory Syncytial Virus (RSV) diagnostics market is experiencing growth driven by several key factors. RSV is a prevalent respiratory virus that can cause severe illness, particularly in infants, the elderly, and individuals with weakened immune systems. This prevalence, coupled with seasonal outbreaks, underscores the need for accurate and timely diagnostics. Advancements in diagnostic technology, including molecular assays like PCR and point-of-care testing (POCT), have enhanced the sensitivity and speed of RSV detection, making diagnostics more efficient and accessible. The availability of rapid POCTs is particularly valuable in clinical settings, reducing the reliance on complex laboratory testing. Increased awareness of RSV's impact, especially among healthcare professionals, has contributed to greater consideration of RSV testing, particularly in pediatric and geriatric care. Public health preparedness and surveillance also rely on RSV diagnostics to track and respond to outbreaks. Additionally, the aging global population and the globalization of travel have raised the risk of severe RSV infections in various regions, further driving the demand for diagnostics. As innovative diagnostic technologies continue to develop and awareness of RSV's severity grows, the market for RSV diagnostics is expected to expand further, ensuring early identification and intervention for this significant respiratory virus.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of respiratory syncytial virus diagnostics. The growth and trends of respiratory syncytial virus diagnostics industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the respiratory syncytial virus diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Direct Fluorescent Antibody (Dfa) Method
  • Rapid Antigen Diagnostic Test (Radt)
  • Molecular Diagnostics
  • Chromatographic Immunoassay (Gravity Driven Test, Oligo Chromatography (Oc))
  • Diagnostic Imaging
  • Gel Microdroplets
  • Flow Cytometry
  • Others

By End-Use

  • Hospitals
  • Laboratory
  • Clinics
  • Homecare

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Respiratory Syncytial Virus Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Respiratory Syncytial Virus Diagnostics market include Becton, Dickinson, and Company, Novartis AG, Abbott, Ortho Clinical Diagnostics, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., BIOMERIEUX, DiaSorin SpA, Merck KGaA, Quidel Corp., Coris BioConcept, Siemens Healthcare SA, Quest Diagnostics Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . RESPIRATORY SYNCYTIAL VIRUS DIAGNOSTICS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By End-Use
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL RESPIRATORY SYNCYTIAL VIRUS DIAGNOSTICS MARKET ANALYSIS BY PRODUCT

  • 5.1 Overview by Product
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Product
  • 5.4 Direct Fluorescent Antibody (Dfa) Method Historic and Forecast Sales by Regions
  • 5.5 Rapid Antigen Diagnostic Test (Radt) Historic and Forecast Sales by Regions
  • 5.6 Molecular Diagnostics Historic and Forecast Sales by Regions
  • 5.7 Chromatographic Immunoassay (Gravity Driven Test, Oligo Chromatography (Oc)) Historic and Forecast Sales by Regions
  • 5.8 Diagnostic Imaging Historic and Forecast Sales by Regions
  • 5.9 Gel Microdroplets Historic and Forecast Sales by Regions
  • 5.10. Flow Cytometry Historic and Forecast Sales by Regions
  • 5.11 Others Historic and Forecast Sales by Regions

6 . GLOBAL RESPIRATORY SYNCYTIAL VIRUS DIAGNOSTICS MARKET ANALYSIS BY END-USE

  • 6.1 Overview by End-Use
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by End-Use
  • 6.4 Hospitals Historic and Forecast Sales by Regions
  • 6.5 Laboratory Historic and Forecast Sales by Regions
  • 6.6 Clinics Historic and Forecast Sales by Regions
  • 6.7 Homecare Historic and Forecast Sales by Regions

7 . GLOBAL RESPIRATORY SYNCYTIAL VIRUS DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2. North America By Segment Sales Analysis
    • 7.3.3. North America By Country Sales Analysis
    • 7.3.4. United State Sales Analysis
    • 7.3.5. Canada Sales Analysis
    • 7.3.6. Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2. Europe by Segment Sales Analysis
    • 7.4.3. Europe by Country Sales Analysis
    • 7.4.4. United Kingdom Sales Analysis
    • 7.4.5. France Sales Analysis
    • 7.4.6. Germany Sales Analysis
    • 7.4.7. Italy Sales Analysis
    • 7.4.8. Russia Sales Analysis
    • 7.4.9. Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2. Asia Pacific by Segment Sales Analysis
    • 7.5.3. Asia Pacific by Country Sales Analysis
    • 7.5.4. China Sales Analysis
    • 7.5.5. India Sales Analysis
    • 7.5.6. Japan Sales Analysis
    • 7.5.7. South Korea Sales Analysis
    • 7.5.8. Australia Sales Analysis
    • 7.5.9. South East Asia Sales Analysis
    • 7.5.10. Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2. Latin America by Segment Sales Analysis
    • 7.6.3. Latin America by Country Sales Analysis
    • 7.6.4. Brazil Sales Analysis
    • 7.6.5. Argentina Sales Analysis
    • 7.6.6. Peru Sales Analysis
    • 7.6.7. Chile Sales Analysis
    • 7.6.8. Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2. Middle East & Africa by Segment Sales Analysis
    • 7.7.3. Middle East & Africa by Country Sales Analysis
    • 7.7.4. Saudi Arabia Sales Analysis
    • 7.7.5. UAE Sales Analysis
    • 7.7.6. Israel Sales Analysis
    • 7.7.7. South Africa Sales Analysis
    • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE RESPIRATORY SYNCYTIAL VIRUS DIAGNOSTICS COMPANIES

  • 8.1. Respiratory Syncytial Virus Diagnostics Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF RESPIRATORY SYNCYTIAL VIRUS DIAGNOSTICS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Becton
    • 9.3.1. Company Overview
    • 9.3.2. Company Revenue
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. Dickinson and Company
    • 9.4.1. Company Overview
    • 9.4.2. Company Revenue
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. Novartis AG
    • 9.5.1. Company Overview
    • 9.5.2. Company Revenue
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. Abbott
    • 9.6.1. Company Overview
    • 9.6.2. Company Revenue
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. Ortho Clinical Diagnostics
    • 9.7.1. Company Overview
    • 9.7.2. Company Revenue
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. Thermo Fisher Scientific Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Company Revenue
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. Bio-Rad Laboratories Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Company Revenue
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. F. Hoffmann-La Roche Ltd.
    • 9.10.1. Company Overview
    • 9.10.2. Company Revenue
    • 9.10.3. Products
    • 9.10.4. Recent Developments
  • 9.11. BIOMERIEUX
    • 9.11.1. Company Overview
    • 9.11.2. Company Revenue
    • 9.11.3. Products
    • 9.11.4. Recent Developments
  • 9.12. DiaSorin SpA
    • 9.12.1. Company Overview
    • 9.12.2. Company Revenue
    • 9.12.3. Products
    • 9.12.4. Recent Developments
  • 9.13. Merck KGaA
    • 9.13.1. Company Overview
    • 9.13.2. Company Revenue
    • 9.13.3. Products
    • 9.13.4. Recent Developments
  • 9.14. Quidel Corp.
    • 9.14.1. Company Overview
    • 9.14.2. Company Revenue
    • 9.14.3. Products
    • 9.14.4. Recent Developments
  • 9.15. Coris BioConcept
    • 9.15.1. Company Overview
    • 9.15.2. Company Revenue
    • 9.15.3. Products
    • 9.15.4. Recent Developments
  • 9.16. Siemens Healthcare SA
    • 9.16.1. Company Overview
    • 9.16.2. Company Revenue
    • 9.16.3. Products
    • 9.16.4. Recent Developments
  • 9.17. Quest Diagnostics Inc.
    • 9.17.1. Company Overview
    • 9.17.2. Company Revenue
    • 9.17.3. Products
    • 9.17.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product (USD MN)
  • Direct Fluorescent Antibody (Dfa) Method Market Sales by Geography (USD MN)
  • Rapid Antigen Diagnostic Test (Radt) Market Sales by Geography (USD MN)
  • Molecular Diagnostics Market Sales by Geography (USD MN)
  • Chromatographic Immunoassay (Gravity Driven Test, Oligo Chromatography (Oc)) Market Sales by Geography (USD MN)
  • Diagnostic Imaging Market Sales by Geography (USD MN)
  • Gel Microdroplets Market Sales by Geography (USD MN)
  • Flow Cytometry Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis Market by End-Use (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Laboratory Market Sales by Geography (USD MN)
  • Clinics Market Sales by Geography (USD MN)
  • Homecare Market Sales by Geography (USD MN)
  • Global Respiratory Syncytial Virus Diagnostics Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Respiratory Syncytial Virus Diagnostics Report
  • Market Research Process
  • Market Research Methodology
  • Global Respiratory Syncytial Virus Diagnostics Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by End-Use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product (USD MN)
  • Direct Fluorescent Antibody (Dfa) Method Market Sales by Geography (USD MN)
  • Rapid Antigen Diagnostic Test (Radt) Market Sales by Geography (USD MN)
  • Molecular Diagnostics Market Sales by Geography (USD MN)
  • Chromatographic Immunoassay (Gravity Driven Test, Oligo Chromatography (Oc)) Market Sales by Geography (USD MN)
  • Diagnostic Imaging Market Sales by Geography (USD MN)
  • Gel Microdroplets Market Sales by Geography (USD MN)
  • Flow Cytometry Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by End-Use (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Laboratory Market Sales by Geography (USD MN)
  • Clinics Market Sales by Geography (USD MN)
  • Homecare Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.